human | Q5 |
P1960 | Google Scholar author ID | TwE02n0AAAAJ |
P10070 | IRIS UNIPG author ID | 35530 |
P6634 | LinkedIn personal profile ID | alessandra-marengoni-b549b838 |
P11718 | OPENBS author ID | 01281 |
P496 | ORCID iD | 0000-0002-4851-1825 |
P69 | educated at | Karolinska Institutet | Q219564 |
P108 | employer | University of Brescia | Q1781263 |
P735 | given name | Alessandra | Q4960889 |
Alessandra | Q4960889 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q40186889 | A Multicomponent Intervention to Optimize Psychotropic Drug Prescription in Elderly Nursing Home Residents: An Italian Multicenter, Prospective, Pilot Study |
Q39021867 | Adherence to Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Prescriptions Affects Overall Medication Adherence in Older Persons: Evidence From the Italian Nationwide OsMed Health-DB Database |
Q40461267 | Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency. |
Q58419014 | Adverse Clinical Events and Mortality During Hospitalization and 3 Months After Discharge in Cognitively Impaired Elderly Patients |
Q39076795 | Assessing and Measuring Chronic Multimorbidity in the Older Population: A Proposal for Its Operationalization. |
Q44881260 | Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study |
Q45764426 | Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study |
Q57285620 | Atrial fibrillation, antithrombotic treatment, and cognitive aging: A population-based study |
Q51035799 | C-reactive protein, lipoprotein (a) and cystatin C levels increase with multimorbidity in older persons. |
Q40235798 | Chronic diseases and geriatric syndromes: The different weight of comorbidity |
Q93152042 | Co-occurrence of cognitive impairment and physical frailty, and incidence of dementia: Systematic review and meta-analysis |
Q40871028 | Coexisting chronic conditions in the older population: Variation by health indicators |
Q39059297 | Combining Gait Speed and Recall Memory to Predict Survival in Late Life: Population-Based Study |
Q33638042 | Comorbidity and progression of late onset Alzheimer's disease: A systematic review |
Q92552481 | Drug Prescription and Delirium in Older Inpatients: Results From the Nationwide Multicenter Italian Delirium Day 2015-2016 |
Q44670806 | Drug-drug interactions in a cohort of hospitalized elderly patients. |
Q40287658 | Effect of Chronic Diseases and Multimorbidity on Survival and Functioning in Elderly Adults |
Q30847108 | Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project). |
Q64280771 | EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research |
Q40736256 | Frailty and Drug Use. |
Q33945995 | Incidence and predictors of multimorbidity in the elderly: a population-based longitudinal study |
Q26781959 | Interventional tools to improve medication adherence: review of literature |
Q58376526 | Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation |
Q104476819 | Multimorbidity Patterns and Unplanned Hospitalisation in a Cohort of Older Adults |
Q57792412 | Multimorbidity and functional impairment: bidirectional interplay, synergistic effects and common pathways |
Q47670424 | Multimorbidity care model: Recommendations from the consensus meeting of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS). |
Q92481329 | Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study |
Q92270166 | Patterns of Multimorbidity in a Population-Based Cohort of Older People: Sociodemographic, Lifestyle, Clinical, and Functional Differences |
Q58376542 | Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study |
Q92169533 | Predicting Cognitive and Functional Trajectories in People With Late-Onset Dementia: 2 Population-Based Studies |
Q44337647 | Prescription drug use among older adults in Italy: a country-wide perspective. |
Q44452297 | Prognostic value of estimated glomerular filtration rate in hospitalized elderly patients |
Q43513337 | Prophylaxis of venous thromboembolism in elderly patients with multimorbidity |
Q50055255 | Rapidly developing multimorbidity and disability in older adults: does social background matter? |
Q58376533 | Risk factors for hospital readmission of elderly patients |
Q36064517 | Scaling up health knowledge at European level requires sharing integrated data: an approach for collection of database specification |
Q47986401 | Social networks and health status in the elderly: the 'ANZIANI IN-RETE' population-based study |
Q37214080 | Socioeconomic status during lifetime and cognitive impairment no-dementia in late life: the population-based aging in the Chianti Area (InCHIANTI) Study |
Q47625353 | The Effect of a 2-Year Intervention Consisting of Diet, Physical Exercise, Cognitive Training, and Monitoring of Vascular Risk on Chronic Morbidity-the FINGER Randomized Controlled Trial |
Q57149761 | The Relationship between Anaemia and Frailty: A Systematic Review and Meta-Analysis of Observational Studies |
Q39434611 | Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study |
Q51765490 | Trajectories of functional decline in older adults with neuropsychiatric and cardiovascular multimorbidity: A Swedish cohort study. |
Q53082927 | Understanding adverse drug reactions in older adults through drug-drug interactions. |
Q92405222 | Walking Speed Drives the Prognosis of Older Adults with Cardiovascular and Neuropsychiatric Multimorbidity |